作者
Maha Hameed, Sakshi Prasad, Esha Jain, Bekir Nihat Dogrul, Ahmad Al-Oleimat, Bidushi Pokhrel, Selia Chowdhury, Edzel Lorraine Co, Saloni Mitra, Jonathan Quinonez, Samir Ruxmohan, Joel Stein
发表日期
2023/4
来源
Current Pain and Headache Reports
卷号
27
期号
4
页码范围
57-63
出版商
Springer US
简介
Purpose of Review
Cannabis has been used since ancient times for medical and recreational research. This review article will document the validity of how medical cannabis can be utilized for chronic nonmalignant pain management.
Recent Findings
Current cannabis research has shown that medical cannabis is indicated for symptom management for many conditions not limited to cancer, chronic pain, headaches, migraines, and psychological disorders (anxiety and post-traumatic stress disorder). Δ9‐Tetrahydrocannabinol (THC) and cannabidiol (CBD) are active ingredients in cannabis that modulate a patient’s symptoms. These compounds work to decrease nociception and symptom frequency via the endocannabinoid system. Research regarding pain management is limited within the USA as the Drug Enforcement Agency (DEA) classifies it as a schedule one drug. Few studies have found a limited …
学术搜索中的文章
M Hameed, S Prasad, E Jain, BN Dogrul, A Al-Oleimat… - Current Pain and Headache Reports, 2023